Investegate announcements from ITM Isotope Technologies Munic, ITM to Present Phase III COMPOSE Poster and Host Satellite Symposium on Radiotheranostics in NET cancer at ENETS Conference
Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the.
Garching / Munich, March 16, 2023 - ITM Isotope Technologies Munich SE) in a poster presentation at the 20th Annual European Neuroendocrine Tumor Society(n.c.a. 177Lu-edotreotide) compared to standard